STP 146G
Alternative Names: STP-146GLatest Information Update: 21 Sep 2022
Price :
$50 *
At a glance
- Originator Sirnaomics
- Class Amides; Amino sugars; Drug conjugates; Small interfering RNA
- Mechanism of Action Complement C3b expression inhibitors; RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Immunological disorders
Most Recent Events
- 30 Aug 2022 Sirnaomics has 119 patents pending applications in multiple countries for siRNAs and mRNA therapeutics (Sirnaomics website, August 2022)
- 30 Aug 2022 Sirnaomics has patent protection in China, Europe and USA for siRNAs and mRNA therapeutics (Sirnaomics website, August 2022)
- 26 Aug 2022 Preclinical trials in Immunological disorders in USA (SC)